Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Tara Esse, PharmD, BCACP
Articles
Medicare Part D Insulin Tiering Change: Impact on Health Outcomes
Alexander T. Nguyen, PharmD;Ruta V. Sawant, MS;Omar Serna, PharmD, BCACP;Tara Esse, PharmD, BCACP;Sujit S. Sansgiry, PhD
October 19th 2016This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: August 30th 2024 | Updated: November 21st 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
Published: October 8th 2024 | Updated: November 21st 2024
What Drug Rates Are Reported in Price Transparency Data?
Published: October 7th 2024 | Updated: November 21st 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
